Description

Ceraxon (Cytokoline) Oral Solution 100 mg/ml. – Sachet 10 ml. – #10

Introduction:

Ceraxon is an oral solution containing 100 mg/ml. of the active ingredient Cytokoline. It is available in a convenient sachet form with a volume of 10 ml. per sachet, packaged in a box of 10 sachets. Ceraxon is commonly prescribed for various conditions and is known for its neuroprotective and cognitive-enhancing properties.

Composition:

Each 10 ml. sachet of Ceraxon contains 100 mg. of Cytokoline as the active ingredient. Inactive ingredients may include excipients such as water, flavorings, preservatives, and stabilizers.

Indications:

Ceraxon is indicated for use in the treatment of various conditions related to cognitive function, memory impairment, and neuroprotection. It is commonly prescribed for patients with conditions such as stroke, traumatic brain injury, dementia, and Alzheimer’s disease.

Mechanism of Action:

Ceraxon works by exerting neuroprotective effects and enhancing cognitive function through its action on various neurotransmitter systems in the brain. Cytokoline, the active ingredient in Ceraxon, helps improve neuronal metabolism, increase cerebral blood flow, and enhance the synthesis of neurotransmitters.

Administration and Dosage:

Ceraxon is typically administered orally as directed by a healthcare provider. The recommended dosage may vary depending on the patient’s condition, age, and overall health. It is important to follow the prescribed dosing schedule and not exceed the recommended dose.

Adverse Reactions:

Like all medications, Ceraxon may cause side effects in some individuals. Common side effects may include gastrointestinal disturbances, headache, dizziness, and allergic reactions. If any adverse reactions occur, it is important to consult a healthcare provider.

Contraindications:

Ceraxon should not be used in patients with known hypersensitivity to Cytokoline or any of the inactive ingredients in the formulation. It is important to inform the healthcare provider of any allergies or sensitivities before starting treatment with Ceraxon.

Precautions:

Patients with certain medical conditions such as renal or hepatic impairment may require dose adjustments or close monitoring while taking Ceraxon. It is important to inform the healthcare provider of any underlying health conditions before starting treatment with Ceraxon.

Storage:

Ceraxon should be stored at room temperature away from moisture and heat. It should be kept out of reach of children and pets. Unused sachets should be properly disposed of according to local regulations.

Conclusion:

Ceraxon is a medication commonly prescribed for its neuroprotective and cognitive-enhancing properties. It is available in a convenient oral solution form with a concentration of 100 mg/ml. of Cytokoline. Patients should follow the prescribed dosing schedule and consult a healthcare provider if any adverse reactions occur. With proper use and monitoring, Ceraxon can be an effective treatment option for various conditions related to cognitive function and neuroprotection.